Amoxicillin/clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute.

Narayanan, Navaneeth; Mathers, Amy J; Wenzler, Eric; Moore, Nicholas M; Giske, Christian G; Mendes, Rodrigo E; Edelstein, Paul H.

Afiliação

Narayanan N; Department of Pharmacy Practice and Administration, Rutgers University Ernest Mario School of Pharmacy, Piscataway, New Jersey, USA.
Mathers AJ; Department of Medicine and Pathology, University of Virginia, Charlottesville, Virginia, USA.
Wenzler E; Roche Diagnostics Corporation, Indianapolis, IN, USA.
Moore NM; Departments of Internal Medicine and Pathology, Rush University Medical Center, Chicago, Illinois, USA.
Giske CG; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden.
Mendes RE; JMI Laboratories, North Liberty, Iowa, USA.
Edelstein PH; Department Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Clin Infect Dis ; 2024 May 06.

Article em En | MEDLINE | ID: mdl-38709848